Molecules and Cells

Cited by CrossRef (35)

  1. Seul-Ki Kim, So Dam Jang, Hyunho Kim, Seok Chung, Jong Kook Park, Hyo-Jeong Kuh. Phenotypic Heterogeneity and Plasticity of Cancer Cell Migration in a Pancreatic Tumor Three-Dimensional Culture Model. Cancers 2020;12:1305
    https://doi.org/10.3390/cancers12051305
  2. Giulia Biondani, Katrine Zeeberg, Maria Raffaella Greco, Stefania Cannone, Ilaria Dando, Elisa Dalla Pozza, Maria Mastrodonato, Stefania Forciniti, Valeria Casavola, Marta Palmieri, Stephan Joel Reshkin, Rosa Angela Cardone. Extracellular matrix composition modulatesPDACparenchymal and stem cell plasticity and behavior through the secretome. FEBS J 2018;285:2104
    https://doi.org/10.1111/febs.14471
  3. Orla Coleman, Michael Henry, Fiona O'Neill, Sandra Roche, Niall Swan, Lorraine Boyle, Jean Murphy, Justine Meiller, Neil Conlon, Justin Geoghegan, Kevin Conlon, Vincent Lynch, Ninfa Straubinger, Robert Straubinger, Gerard McVey, Michael Moriarty, Paula Meleady, Martin Clynes. A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts. Proteomes 2018;6:45
    https://doi.org/10.3390/proteomes6040045
  4. Taylor J. Allen-Coyle, Jin Niu, Eva Welsch, Neil T. Conlon, Weylon Garner, Martin Clynes, Finbarr O’Sullivan, Robert M. Straubinger, Donald E. Mager, Sandra Roche. FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures. AAPS J 2022;24
    https://doi.org/10.1208/s12248-022-00752-8
  5. Dacheng Xie, Keping Xie. Pancreatic cancer stromal biology and therapy. Genes & Diseases 2015;2:133
    https://doi.org/10.1016/j.gendis.2015.01.002
  6. Jana Jandova, Jean‐Philippe Galons, David L. Dettman, Georg T. Wondrak. Systemic deuteration of SCID mice using the water‐isotopologue deuterium oxide (D2O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma. Molecular Carcinogenesis 2023;62:598
    https://doi.org/10.1002/mc.23509
  7. Nils Elander, Karen Aughton, William Greenhalf. Pancreatic Cancer. 2023.
    https://doi.org/10.1007/978-1-4939-7193-0_59
  8. Xiu Hu, Wei Chen. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma. WJCC 2021;9:4998
    https://doi.org/10.12998/wjcc.v9.i19.4998
  9. Do Luong Huynh, Hyebin Koh, Nisansala Chandimali, Jiao Jiao Zhang, Nameun Kim, Tae Yoon Kang, Mrinmoy Ghosh, Meeta Gera, Yang-Ho Park, Taeho Kwon, Dong Kee Jeong. BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic Hedgehog Signaling. Evidence-Based Complementary and Alternative Medicine 2019;2019:1
    https://doi.org/10.1155/2019/8620469
  10. Ryne C. Ramaker, Andrew A. Hardigan, Emily R. Gordon, Carter A. Wright, Richard M. Myers, Sara J. Cooper. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition. BMC Cancer 2021;21
    https://doi.org/10.1186/s12885-021-08388-1
  11. Johannes F. Fahrmann, Hiroyuki Katayama, Ehsan Irajizad, Ashish Chakraborty, Taketo Kato, Xiangying Mao, Soyoung Park, Eunice Murage, Leona Rusling, Chuan-Yih Yu, Yinging Cai, Fu Chung Hsiao, Jennifer B. Dennison, Hai Tran, Edwin Ostrin, David O. Wilson, Jian-Min Yuan, Jody Vykoukal, Samir Hanash. Plasma Based Protein Signatures Associated with Small Cell Lung Cancer. Cancers 2021;13:3972
    https://doi.org/10.3390/cancers13163972
  12. Nik Nur Syazni Nik Mohamed Kamal, Fatin Athirah Abdul Aziz, Wen-Nee Tan, Agustine Nengsih Fauzi, Vuanghao Lim. Mechanistic Actions between Garcinia atroviridis Essential Oil and 2 Deoxy-d-glucose in Cultured PANC-1 Human Pancreatic Cancer Cells. Molecules 2021;26:3518
    https://doi.org/10.3390/molecules26123518
  13. Shenao Fu, Shaokang Xu, Shubing Zhang. The role of amino acid metabolism alterations in pancreatic cancer: From mechanism to application. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023;1878:188893
    https://doi.org/10.1016/j.bbcan.2023.188893
  14. Hyunsoo Kim, Joonho Park, Joseph I. Wang, Youngsoo Kim. Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead. Expert Review of Proteomics 2017;14:963
    https://doi.org/10.1080/14789450.2017.1382356
  15. Nils Elander, Karen Aughton, William Greenhalf. Pancreatic Cancer. 2017.
    https://doi.org/10.1007/978-1-4939-6631-8_59-1
  16. Kunal P. Pednekar, Marcel A. Heinrich, Joop van Baarlen, Jai Prakash. Novel 3D µtissues Mimicking the Fibrotic Stroma in Pancreatic Cancer to Study Cellular Interactions and Stroma-Modulating Therapeutics. Cancers 2021;13:5006
    https://doi.org/10.3390/cancers13195006
  17. Xuan Huang, Haiyang Zhang, Haiyue Cao, Wei Zhou, Xin Xiang, Zhaozheng Yin. Transcriptomics and Metabolomics Analysis of the Ovaries of High and Low Egg Production Chickens. Animals 2022;12:2010
    https://doi.org/10.3390/ani12162010
  18. Mehdi El Amrani, François Corfiotti, Matthieu Corvaisier, Romain Vasseur, Maxence Fulbert, Cécile Skrzypczyk, Anne‐Claire Deshorgues, Viviane Gnemmi, David Tulasne, Fatima Lahdaoui, Audrey Vincent, François‐René Pruvot, Isabelle Seuningen, Guillemette Huet, Stéphanie Truant. Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotype. Mol Carcinog 2019;58:1985
    https://doi.org/10.1002/mc.23090
  19. Pei-wen Yang, Ju-ying Jiao, Zhen Chen, Xiao-yan Zhu, Chien-shan Cheng. Keep a watchful eye on methionine adenosyltransferases, novel therapeutic opportunities for hepatobiliary and pancreatic tumours. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022;1877:188793
    https://doi.org/10.1016/j.bbcan.2022.188793
  20. Guillaume Rieunier, Xiaoning Wu, Letitia E. Harris, Jack V. Mills, Ashwin Nandakumar, Laura Colling, Elena Seraia, Stephanie B. Hatch, Daniel V. Ebner, Lisa K. Folkes, Ulrike Weyer-Czernilofsky, Thomas Bogenrieder, Anderson J. Ryan, Valentine M. Macaulay. Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction. 2021;81:2128
    https://doi.org/10.1158/0008-5472.CAN-20-2860
  21. Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, Paul B. Fisher, Luni Emdad. Pancreatic Cancer: Basic Mechanisms and Therapies. 2021.
    https://doi.org/10.1016/bs.acr.2023.02.010
  22. Qingxiang Lin, Shichen Shen, Zhicheng Qian, Sailee S. Rasam, Andrea Serratore, William J. Jusko, Eugene S. Kandel, Jun Qu, Robert M. Straubinger. Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer. Molecular & Cellular Proteomics 2022;21:100409
    https://doi.org/10.1016/j.mcpro.2022.100409
  23. Yao An, Li Zhou, Zhao Huang, Edouard C. Nice, Haiyuan Zhang, Canhua Huang. Molecular insights into cancer drug resistance from a proteomics perspective. Expert Review of Proteomics 2019;16:413
    https://doi.org/10.1080/14789450.2019.1601561
  24. Alastair J. Hayes, Christos Skouras, Beate Haugk, Richard M. Charnley. Keap1–Nrf2 signalling in pancreatic cancer. The International Journal of Biochemistry & Cell Biology 2015;65:288
    https://doi.org/10.1016/j.biocel.2015.06.017
  25. Adriana Carneiro, Paulina Piairo, Alexandra Teixeira, Dylan Ferreira, Sofia Cotton, Carolina Rodrigues, Alexandre Chícharo, Sara Abalde-Cela, Lúcio Lara Santos, Luís Lima, Lorena Diéguez. Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients. Cells 2022;11:376
    https://doi.org/10.3390/cells11030376
  26. Orla Coleman, Michael Henry, Gerard McVey, Martin Clynes, Michael Moriarty, Paula Meleady. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact. Expert Review of Proteomics 2016;13:383
    https://doi.org/10.1586/14789450.2016.1167601
  27. Song Han, Zhiguang Huo, Kathy Nguyen, Fanchao Zhu, Patrick W Underwood, Kari B Green Basso, Thomas J. George, Steven J. Hughes. The Proteome of Pancreatic Cancer‐Derived Exosomes Reveals Signatures Rich in Key Signaling Pathways. Proteomics 2019:1800394
    https://doi.org/10.1002/pmic.201800394
  28. Daniele Vergara, Pasquale Simeone, Julien Franck, Marco Trerotola, Anna Giudetti, Loredana Capobianco, Andrea Tinelli, Claudia Bellomo, Isabelle Fournier, Antonio Gaballo, Saverio Alberti, Michel Salzet, Michele Maffia. Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics. EuPA Open Proteomics 2016;10:31
    https://doi.org/10.1016/j.euprot.2016.01.003
  29. Tiziana Tataranni, Francesca Agriesti, Vitalba Ruggieri, Carmela Mazzoccoli, Vittorio Simeon, Ilaria Laurenzana, Rosella Scrima, Valerio Pazienza, Nazzareno Capitanio, Claudia Piccoli. Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles. Oncotarget 2017;8:41265
    https://doi.org/10.18632/oncotarget.17172
  30. Stefania Cannone, Maria Raffaella Greco, Tiago M. A. Carvalho, Helene Guizouarn, Olivier Soriani, Daria Di Molfetta, Richard Tomasini, Katrine Zeeberg, Stephan Joel Reshkin, Rosa Angela Cardone. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition. Cancers 2022;14:3737
    https://doi.org/10.3390/cancers14153737
  31. Eliana Steinberg, Natalie Orehov, Katerina Tischenko, Ouri Schwob, Gideon Zamir, Ayala Hubert, Zakhariya Manevitch, Ofra Benny. Rapid Clearing for High Resolution 3D Imaging of Ex Vivo Pancreatic Cancer Spheroids. IJMS 2020;21:7703
    https://doi.org/10.3390/ijms21207703
  32. Lei Chang, Peter Graham, Jingli Hao, Joseph Bucci, David Malouf, David Gillatt, Yong Li. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy. Cancer Letters 2015;369:289
    https://doi.org/10.1016/j.canlet.2015.09.013
  33. Meztli Matadamas-Guzman, Cecilia Zazueta, Emilio Rojas, Osbaldo Resendis-Antonio. Analysis of Epithelial-Mesenchymal Transition Metabolism Identifies Possible Cancer Biomarkers Useful in Diverse Genetic Backgrounds. Front. Oncol. 2020;10
    https://doi.org/10.3389/fonc.2020.01309
  34. Yukun Sun, Guangdong Wu, Kok Suen Cheng, Anqi Chen, Kuang Hong Neoh, Shuiyu Chen, Zhewen Tang, Poh Foong Lee, Menghua Dai, Ray P.S. Han. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients. EBioMedicine 2019;46:133
    https://doi.org/10.1016/j.ebiom.2019.07.044
  35. Concetta Panebianco, Federica Pisati, Annacandida Villani, Annapaola Andolfo, Marynka Ulaszewska, Edoardo Bellini, Carmelapia Ferro, Renato Lombardi, Fabrizio Orsenigo, Tiziana Pia Latiano, Beatrice Belmonte, Claudio Tripodo, Francesco Perri, Valerio Pazienza. Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model. Cell Death Discov. 2023;9
    https://doi.org/10.1038/s41420-023-01397-y